Safe Harbor Statement
Statements made in this press release related to the business outlook and future financial performance of Pharmos, to the prospective market penetration of its drug products, to the development and commercialization of its pipeline products and to its expectations in connection with any future event, condition, performance or other matter, are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause results to differ materially from those set forth in these statements. Additional economic, competitive, governmental, technological, marketing and other factors identified in Pharmos' filings with the Securities and Exchange Commission could affect such results.
Consolidated Statements of Operations
Three months ended Nine months ended
September 30, September 30,
2007 2006 2007 2006
gross $2,711,774 $2,338,392 $9,285,543 $6,587,480
Grants (238,123) (415,203) (769,072) (1,083,464)
of grants 2,473,651 1
|SOURCE Pharmos Corporation|
Copyright©2007 PR Newswire.
All rights reserved